A clinical trial to study the rubrics(symptoms in Repertory) of two drugs, Carcinosin and Tuberculinum from Index(Repertory) called Homoeopathic Medical Repertory by Robin Murphy 3rd edition.

Clinical verification of rubrics of Carcinosin and Tuberculinum from Homoeopathic Medical Repertory by Robin Murphy 3rd edition. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065480

Enrollment

Registered

2024-04-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: CARCINOSIN AND TUBERCULINUM: MEDICINE WILL BE GIVEN IN DIFFERENT POTENCIES AS PER THE REQUIREMENT OF CASES Control Intervention1: NOT APPLICABLE: NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: 1.The cases where remedies Carcinosin and Tuberculinum will be indicated. 2.Age: Cases up to 70 years of age. 3.Sex: Both sexes.

Exclusion criteria

Exclusion criteria: 1.Cases that need emergency treatment will be excluded. 2.Female cases having pregnancy will be excluded.

Design outcomes

Primary

Measure	Time frame
DECREASE IN MEASURE YOURSELF MEDICAL OUTCOME PROFILE-2 SCORETimepoint: MEASURE YOURSELF MEDICAL OUTCOME PROFILE-2 FOLLOW UP SCORE WILL BE TAKEN EVERY 7,15,30 days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactAAYUSHIBEN NILESHBHAI PATEL

Dr. V. H. Dave Homoeopathic Medical college

dr.meerashah@yahoo.com9898692003

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026